Updated: March 26, 2026
What Is Tiagabine? Uses, Dosage, and What You Need to Know in 2026
Author
Peter Daggett

Summarize with AI
Tiagabine (Gabitril) is an anticonvulsant used to treat partial seizures. Here's a complete guide to what it is, how it's used, and what patients need to know in 2026.
Tiagabine, sold under the brand name Gabitril, is an FDA-approved anticonvulsant medication used to help control partial (focal) seizures in people with epilepsy. It was first approved by the FDA in 1997 and is available today in both brand-name and generic forms. Here's everything patients and caregivers need to know about tiagabine in 2026.
What Is Tiagabine Used For?
Tiagabine is FDA-approved as adjunctive therapy — meaning it is used in combination with other antiepileptic drugs (AEDs), not on its own — for partial seizures in adults and children 12 years and older. It is specifically indicated for patients whose seizures are not fully controlled on existing medications.
Partial seizures (also called focal seizures) are seizures that begin in one part of the brain. They can be simple (consciousness maintained) or complex (consciousness impaired), and may or may not spread to become generalized seizures.
Is Tiagabine Used for Anything Besides Epilepsy?
Tiagabine has been studied and used off-label for several other conditions, including anxiety disorders (panic disorder, social anxiety disorder), insomnia, neuropathic pain, and PTSD. However, the FDA has not approved it for these uses, and off-label use is strongly discouraged by the FDA because tiagabine has caused new-onset seizures — including in people without epilepsy — when used outside its approved indication.
The American Academy of Sleep Medicine's 2017 guidelines specifically recommended against using tiagabine for insomnia due to limited evidence and safety concerns.
Is Tiagabine a Controlled Substance?
No. Tiagabine (Gabitril) is not a controlled substance under federal DEA scheduling. It is a prescription-only medication, but it does not carry any special DEA restrictions for prescribing or dispensing.
What Dosage Forms Does Tiagabine Come In?
Tiagabine is available as oral tablets in the following strengths:
2 mg — typically used to start therapy at a very low dose
4 mg — the most commonly prescribed starting and maintenance dose
12 mg — higher-dose maintenance tablets
16 mg — used for higher-dose maintenance, particularly in induced patients
There is no extended-release or liquid formulation of tiagabine. The tablets must be taken multiple times daily due to a relatively short half-life (4.5-9 hours).
How Is Tiagabine Dosed?
Dosing depends on whether the patient is also taking enzyme-inducing antiepileptic drugs (AEDs) like carbamazepine, phenytoin, phenobarbital, or primidone. These drugs speed up the breakdown of tiagabine in the liver, requiring higher doses.
Starting dose (adults): 4 mg once daily for the first week
Titration: Dose is increased by 4-8 mg per week as tolerated
Maximum dose (induced patients): 56 mg/day in 2-4 divided doses
Maximum dose (non-induced patients): 32 mg/day
For adolescents 12-18 years: Start at 4 mg once daily; increase by 4 mg per week; maximum 32 mg/day in induced patients.
How Should You Take Tiagabine?
Always take with food. Taking tiagabine on an empty stomach affects absorption and increases the risk of GI side effects.
Take at the same times each day. Consistent timing helps maintain stable blood levels.
Never stop abruptly. Always taper under your doctor's supervision.
Wear a medical alert bracelet. Inform emergency medical providers that you take an antiepileptic drug.
What Should You Avoid While Taking Tiagabine?
Alcohol — worsens CNS side effects significantly
Driving until you know how the medication affects you
Grapefruit juice — may affect metabolism (discuss with your doctor)
St. John's Wort — can reduce tiagabine blood levels
For information on how tiagabine works in the brain, see our guide: How does tiagabine work? Mechanism of action explained. If you need help finding tiagabine at a pharmacy near you, medfinder can search on your behalf.
Frequently Asked Questions
Tiagabine (brand name Gabitril) is FDA-approved as adjunctive therapy for partial (focal) seizures in adults and children 12 years and older with epilepsy. It is used in combination with other antiepileptic drugs when seizures are not fully controlled on existing medications alone.
Tiagabine is typically taken 2-4 times per day due to its short elimination half-life of 4.5-9 hours. Your doctor will specify your dosing schedule. Many patients take it with meals and at bedtime to help remember doses and reduce GI side effects.
Tiagabine is FDA-approved only as adjunctive therapy — used together with other AEDs, not alone. Studies have shown some efficacy as monotherapy in newly diagnosed partial epilepsy, but this is not an approved indication and safety concerns about off-label use make this uncommon in practice.
The maximum dose of tiagabine is 56 mg/day for patients also taking enzyme-inducing AEDs (carbamazepine, phenytoin, phenobarbital, primidone). For patients not on these drugs (non-induced), the maximum is generally 32 mg/day. Dosing is individualized based on response and tolerability.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Tiagabine also looked for:
More about Tiagabine
36,837 have already found their meds with Medfinder.
Start your search today.





